A Phase 2a study of MTX-463 in Idiopathic Pulmonary Fibrosis (IPF)

Recruiting Phase 2 NCT06967805

Study Description

A Study to Evaluate the Safety and Effectiveness of an Investigational Drug (MTX-463) in Patients with Idiopathic Pulmonary Fibrosis

Study Details

Registry ID:
NCT06967805
Conditions:
Idiopathic Pulmonary Fibrosis
Phase:
Phase 2
Target Enrollment:
164 participants
Start Date:
Healthy Volunteers:
No

Study Locations (75 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.org.

View full study details and check eligibility →